{"id":51912,"name":"AMYLYX PHARMACEUTICALS","slug":"amylyx-pharmaceuticals","state":"MA","country":"United States of America","description":"Company dedicated to the development of potential therapies for neurodegenerative diseases","totalSpending":990000,"filings":17,"yearlySpending":[{"year":2022,"income":270000},{"year":2023,"income":320000},{"year":2024,"income":240000},{"year":2025,"income":160000}],"issues":["HCR","MMM"],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["ELIZABETH MURRAY","CHARLOTTE IVANCIC","EMILY MURRY","KIMBERLY BRANDT","RAISSA DOWNS","MICHELLE EASTON","JENNIFER YOUNG","PAMELA SMITH","MARGARET JOSEPH","PETER FISE","LAURA FRIEDEL","PARICK CARROLL"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["ALS and access to innovation","ALS and access to innovation","ALS and access to innovation","ALS and access to innovation","ALS and access to innovation"],"years":[2022,2023,2024,2025]}